Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Roche CEO Warns Against 'Middle Ground' Approach To Combat Pricing Pressure

This article was originally published in Scrip

Executive Summary

Roche Holding AG's CEO Severin Schwan says the only surefire way to beat pricing pressures is to focus on "highly innovative medicines, differentiated medicines, medicines which provide significant value for patients". By doing this Roche has been "less exposed to price pressure not only in the US, but worldwide, and we see that in the numbers." The company reported third quarter sales on Oct. 22 that beat expectations.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC030125

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel